Key facts
- uLink Labs’s last known valuation is $32.6M (Dec 2025).
- It has raised $15.6M across 2 recorded rounds; the latest was Early Stage VC ($8.6M) in Nov 2025.
- Notable investors include Sonder Capital Management.
- uLink Labs has filed 1 Form D with the SEC, most recently Jun 2021 ($4.8M sold to 3 investors).
- Status: Privately Held (backing).
Investors
1Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for uLink Labs
Create free account
No card required
Funding rounds
2 roundsAbout uLink Labs
Developer of a medical device designed to innovate sustainable next-generation medical devices. The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- San Mateo, CA, United States
- Founded
- 2019
- Website
- ulink-labs.com/
- Ownership
- Privately Held (backing)
PA Mark — not yet priced
uLink Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in uLink Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on uLink Labs in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.